Delivery Order SPE2DB22D3501-SPE2DB25FWS44
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ultane 250 mL pen bottle pharmaceutical product with a ceiling value of $1,443.90. Issued on August 5, 2025, this firm fixed price contract represents a non-set-aside, competitively awarded delivery order with an ultimate completion date of August 6, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the place of performance for this award, reflecting the...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Ultane Liquid 250ML, with a firm fixed price ceiling value of $2,816.90 and completion targeted for August 19, 2025. This competitively awarded, non-set-aside delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with the Defense Logistics Agency Troop Support Medical, valued at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,780.81 by the Defense Logistics Agency (DLA) on August 13, 2025, with an ultimate completion date of August 14, 2025. The contract, designated as a child order under a larger indefinite delivery contract (IDC), covers the supply of Ultane 250 mL pen bottle medication. This delivery order was competitively awarded with firm fixed-price pricing...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 250 ML pen bottles of the pharmaceutical product ULTANE. The contract has a completion date of February 1, 2024 and a potential value of $1,157.75. Amerisourcebergen Drug Corp is the prime contractor and this delivery order is issued under a larger indefinite delivery contract (IDC) with DLA Troop Support Medical,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation. The contract, valued at $1,892.36, is for the supply of ULTANE 250 ML PEN BOTTLE 250ML, a pharmaceutical product. The contract has an ultimate completion date of August 28, 2024 and is a Firm Fixed Price type. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product Ultane 250 ML Pen Bottle 250ML. The contract has a ceiling value of $2,778.60 and a period of performance through April 2, 2024. This award is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, which has a potential value of up to $999,999,999.00...
- The Defense Logistics Agency awarded a $2,814 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561375747 ULTANE 250 ML PEN BOTTLE 250ML. The contract has a period of performance from June 29, 2023 through June 30, 2023. Amerisourcebergen will deliver the pharmaceutical products to its facility located in Conshohocken, Pennsylvania in support of the Defense Logistics Agency's medical supply chain requirements. No major subcontractors or set aside designations were...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,111.44 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of ULTANE 250 ML PEN BOTTLE 250ML pharmaceutical products and has a performance period through March 29, 2024. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) from DLA valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,686.99, is for the delivery of Ultane 250 ML Pen Bottles. The contract has a completion date of February 7, 2025, and is a firm fixed-price contract. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) and has a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,443.90, is for the supply of ULTANE 250 ML PEN BOTTLE 250ML, a medical product. The contract has a firm fixed price pricing type and an ultimate completion date of March 18, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWS44Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Ultane 250 mL pen bottles with a ceiling value of $1,155.12. This firm fixed price delivery order, which must be completed by August 5, 2025, represents a competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The company's extensive portfolio of federal contracts demonstrates its capability to deliver a wide range of pharmaceutical products and medical supplies across multiple therapeutic domains. This specific delivery order for Ultane, a volatile anesthetic agent used in medical procedures, exemplifies the company's role in supplying essential pharmaceutical commodities to support Department of Defense healthcare operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 8/4/25 |